LONDON--(BUSINESS WIRE)--Smith & Nephew (NYSE:SNN; LSE:SN), the global medical technology business, welcomes the launch of new medical technologies guidance from the UK National Institute for Health ...
We have moved Medical technologies guidance 43 to become HealthTech guidance 509. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results